Genprex, Inc. (GNPX)
NASDAQ: GNPX · Real-Time Price · USD
0.2160
-0.0092 (-4.09%)
At close: Aug 14, 2025, 4:00 PM
0.2198
+0.0038 (1.76%)
After-hours: Aug 14, 2025, 6:48 PM EDT
Genprex Market Cap
Genprex has a market cap or net worth of $7.16 million as of August 14, 2025. Its market cap has increased by 89.80% in one year.
Market Cap
7.16M
Enterprise Value
3.69M
1-Year Change
89.80%
Ranking
Category
Stock Price
$0.22
Market Cap Chart
Since March 29, 2018, Genprex's market cap has decreased from $61.26M to $7.16M, a decrease of -88.31%. That is a compound annual growth rate of -25.23%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2025 | 7.16M | -1.19% |
| Dec 31, 2024 | 7.25M | -47.00% |
| Dec 29, 2023 | 13.67M | -80.37% |
| Dec 30, 2022 | 69.64M | 11.19% |
| Dec 31, 2021 | 62.63M | -64.95% |
| Dec 31, 2020 | 178.67M | 2,798.45% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Mar 29, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 614.44B |
| Johnson & Johnson | 420.78B |
| AbbVie | 361.58B |
| UnitedHealth Group | 245.88B |
| AstraZeneca | 240.81B |
| Novartis AG | 236.22B |
| Novo Nordisk | 225.09B |
| Abbott Laboratories | 225.01B |